Halozyme Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Halozyme Therapeutics's balance sheet done over the years? Its assets were worth $1,733,270,000 last year, which is less than in the previous period. 95% of Halozyme Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $1,649,462,000, which means an decrease by -1% compared compared to last year.
Debt to Assets
| 2014 | 165977000 | 124.62M | 75.09% |
|---|---|---|---|
| 2015 | 181789000 | 138.79M | 76.35% |
| 2016 | 261515000 | 293.99M | 112.42% |
| 2017 | 519945000 | 311.57M | 59.93% |
| 2018 | 440248000 | 191.36M | 43.47% |
| 2019 | 565874000 | 474.10M | 83.78% |
| 2020 | 579924000 | 428.87M | 73.95% |
| 2021 | 1104429000 | 907.47M | 82.17% |
| 2022 | 1841511000 | 1.67B | 90.78% |
| 2023 | 1733270000 | 1.64B | 95.16% |
0J2O.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 118.37M | 234.19M | 118.71M | 147.70M | 120.17M | 57.93M | 168.74M | 66.76M | 43.29M | 61.38M |
Short term investments | 217.63M | 128.59M | 622.20M | 220.31M | 301.08M | 296.59M | 300.47M | 138.21M | 65.04M | 74.23M |
Net receivables | 234.21M | 231.07M | 90.97M | 97.73M | 59.44M | 30.00M | 22.13M | 15.68M | 32.41M | 9.14M |
Inventory | 127.60M | 100.12M | 53.90M | 60.74M | 29.35M | 22.62M | 5.14M | 14.62M | 9.48M | 6.40M |
Other current assets | 48.61M | 45.02M | 40.48M | 28.27M | 33.37M | 20.69M | 27.75M | 21.24M | 43.06M | 20.28M |
Total current assets | 746.42M | 739.01M | 926.28M | 554.76M | 543.43M | 427.84M | 510.37M | 256.53M | 171.77M | 161.32M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 74.94M | 75.57M | 8.79M | 10.59M | 10.85M | 7.46M | 3.52M | 4.26M | 3.94M | 2.95M |
Goodwill | 416.82M | 409.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 472.87M | 546.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 500K | 500K | 500K | 500K | 0 | 500K | 0 | 500K | 0 |
Other non-current assets | 17.81M | 26.30M | 13.91M | 14.06M | 11.08M | 4.93M | 5.55M | 719K | 5.57M | 1.70M |
Total non-current assets | 986.84M | 1.10B | 178.14M | 25.16M | 22.43M | 12.39M | 9.57M | 4.98M | 10.01M | 4.65M |
Total assets | 1.73B | 1.84B | 1.10B | 579.92M | 565.87M | 440.24M | 519.94M | 261.51M | 181.78M | 165.97M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 3.24M | 1.74M | 1.74M | 4.01M | 4.24M | 6.56M | 4.79M | 9.30M | 7.36M |
Short term debt | 0 | 13.33M | 89.41M | 397.22M | 19.54M | 91.50M | 77.21M | 17.39M | 21.86M | 0 |
Total current liabilities | 112.49M | 130.78M | 117.14M | 421.38M | 85.63M | 149.36M | 131.32M | 54.58M | 62.45M | 24.33M |
| Non-current liabilities: | ||||||||||
Long term debt | 1.49B | 1.49B | 787.25M | 3.46M | 383.04M | 34.87M | 125.14M | 199.22M | 27.97M | 49.86M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 37.72M | 45.90M | 544K | 3.46M | 4.18M | 2.11M | 814K | 358K | 4.44M | 3.16M |
Total non-current liabilities | 1.53B | 1.54B | 790.32M | 7.49M | 388.47M | 42M | 180.25M | 239.41M | 76.33M | 100.29M |
Total liabilities | 1.64B | 1.67B | 907.47M | 428.87M | 474.10M | 191.36M | 311.57M | 293.99M | 138.79M | 124.62M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |